Monteris Medical (Plymouth, Minn.) recently announced that it received Health Canada approval for its NeuroBlate Fusion-S software.
The Fusion-S software display offers a visual representation of critical anatomical details to allow neurosurgeons to easily view brain structures throughout a procedure, according to the company. The software also features 3D views for an advanced graphical interface to optimally define lesion anatomy.
Monteris Medical’s software was designed to build upon established safety features in the NeuroBlate system, which includes an unlimited number of temperature pick points that can be set at any location in the three-dimensional ablation zone to monitor ablation progress and avoid the complex structure of the brain.
“We are proud of our software center of excellence in Winnipeg, which continues to innovate and advance the NeuroBlate technology, along with our engineering teams in the U.S.,” Richard Tyc, cofounder and VP of technology and advanced development, said in a news release. “Monteris has grown and expanded beyond its Manitoba roots, but Winnipeg remains home for a team of dedicated professionals advancing this new tool for neurosurgeons and their patients.”
The NeuroBlate System has been used in more than 450 cases and was FDA-cleared in January 2020.
“Monteris continues to innovate in ways that are meaningful for neurosurgeons and our patients,” Dr. Brian William, a neurosurgeon at the University of Louisville, said. “The launch of Fusion-S software represents a significant leap forward for the broader field of laser ablation for the brain. The views I have with this software offer a level of precision that is so critical for every procedure.”
